OrbiMed is a healthcare-focused investment firm based in New York City, established in 1989. The firm specializes in providing a range of financing solutions, including bridge loans, senior debt, and structured debt capital for both commercial-stage public and private healthcare companies. OrbiMed invests across various sectors within the healthcare industry, such as pharmaceuticals, life sciences, digital health, medical devices, biopharmaceuticals, diagnostics, healthcare technology, and biotechnology. With approximately $5 billion in assets under management, OrbiMed aims to support a spectrum of healthcare companies, from early-stage ventures to established multinational corporations.
601 Lexington Avenue (at 53rd Street), 54th Floor New York, NY 10022-4629
1700 Owens Street Suite 540 San Francisco, CA 94158
Suite F 27, Grand Hyatt Plaza Santacruz (East) Mumbai, 400055, India
89 Medinat HaYehudim St Building E, 11th Floor Herzliya 4614001, Israel
Unit 4706, Raffles City Shanghai Office Tower 268 Xizang Middle Road Shanghai 200001, P.R. China
12/F International Commerce Centre 1 Austin Road West, Unit 01 Kowloon, Hong Kong
Ashiya Ph.D., Mona
Private Equity Partner
Sven H. Borho
Partner
Evan Caplan
Principal
Sumona Chakraborty
Director
Lars Enstrom
Managing Director
Joshua Golomb
Partner, Public Equity
Gordon C.F.A., Ph.D., CFA, Carl L.
Managing Partner
Rishi Gupta
Private Equity Partner
Geoffrey C. Hsu
Partner
Alexandria Huynh
Analyst
Mark R. Jelley
Partner
Kip Kitur
Vice President, Private Equity
Kevin Koch
Venture Partner
Jonathan Lee
Partner
Yifu Liu
Managing Director, Asia
Jonathan Mandelbaum Ph.D
Vice President, Private Equity
John McGrath
Venture Partner
Neild CFA, W. Carter
Partner
Topher Orr
Partner
Trevor M. Polischuk
Public Equity Partner
Matthew S. Rizzo
General Partner
William F. Sawyer
Public Equity Partner
Sunny Sharma
Senior Managing Director
Michael B. Sheffery
Partner and Co-Founder
Natasha Shervani
Vice President
Silverstein J.D., Esq., Jonathan Todd
Co-Head of Private Equity and Managing Partner
Charles Steinman
Analyst
C. Scotland Stevens
Public Equity Partner
Veitinger M.B.A., M.D., MBA, Ph.D., Klaus R.
Venture Partner
Wang, Clive
Associate
David Wang
Partner and Senior Managing Director, Asia
Conrad Wang
Principal
Wang C.F.A., Iris
Partner
Dimitrios Weedon
Managing Director
Wessel, Tadd S.
Managing Director
Matthew L. Wotiz
Principal
Stella Xing
Managing Director
Diyong Xu
Principal, Private Equity / Venture Capital
Henry Yang
Vice President, Asia
Nate Yee
Principal
Jessica Zhang Ph.D
Senior Associate
Zhou, Daniel
Managing Director
Guowei Wang Ph.D
Senior Managing Director, Asia and Partner
Steven Wang Ph.D
Partner
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.